AI Archives · BioBuzz

Artificial Intelligence in Cancer Research and Clinical Care Symposium

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/07/Hood-Symposium-image-300x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/07/Hood-Symposium-image-scaled-75x75.jpg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/07/Hood-Symposium-image-150x150.jpg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/07/Hood-Symposium-image.jpg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/07/Hood-Symposium-image-300x300.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : August 8, 2022September 21, 2022 Published by : Chris Frew

The Artificial Intelligence in Cancer Research and Clinical Care Symposium—the second in the Hood College-Frederick National Laboratory for Cancer Research Life Sciences Symposium Series—will showcase the latest applications of AI [….]

IndyGeneUS AI and the Blockchain-Secured Genomic Data Marketplace

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-300x300.jpeg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-75x75.jpeg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-150x150.jpeg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-300x300.jpeg?lossy=1&strip=1&webp=1 300w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-e1652315080929.jpeg?lossy=1&strip=1&webp=1 400w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-640x640.jpeg?lossy=1&strip=1&webp=1 640w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-675x675.jpeg?lossy=1&strip=1&webp=1 675w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-768x768.jpeg?lossy=1&strip=1&webp=1 768w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/05/yusuf-800x800.jpeg?lossy=1&strip=1&webp=1 800w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : May 12, 2022May 12, 2022 Published by : Alex Keown

IndyGeneUS AI and the Blockchain-Secured Genomic Data Marketplace IndyGeneUS AI, which is harnessing the power of data mining and artificial intelligence to expedite the development and manufacturing of targeted therapeutics, [….]

Red Cell Forms Zephyr AI to Revolutionize Drug Discovery and Precision Medicine

<img width="300" height="117" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/Zephyr-Ai-300x117.jpeg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="Zephyr AI Logo" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/Zephyr-Ai.jpeg?size=60x23&lossy=1&strip=1&webp=1 60w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/Zephyr-Ai.jpeg?size=120x47&lossy=1&strip=1&webp=1 120w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/Zephyr-Ai.jpeg?size=180x70&lossy=1&strip=1&webp=1 180w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/Zephyr-Ai.jpeg?size=240x94&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2021/11/Zephyr-Ai-300x117.jpeg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : November 23, 2021November 23, 2021 Published by : BioBuzz Media

Zephyr AI’s mission is to transform drug discovery, redefine personalized medicine, and empower healthcare systems to achieve better patient outcomes at lower cost. Zephyr AI integrates artificial intelligence with extensive datasets to upend traditional “guess and test” drug development and personalized medicine processes to unearth novel therapeutics, new applications for existing therapeutics, and advanced biomarkers for individualized treatments.

BioTalk Podcast w/ 20/20 Gene Systems CEO Johnathan Cohen

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/05/Biotalk-Jcohen-300x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/05/Biotalk-Jcohen-100x100.jpg?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/05/Biotalk-Jcohen-150x150.jpg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/05/Biotalk-Jcohen.jpg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/05/Biotalk-Jcohen-300x300.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : May 17, 2018September 26, 2020 Published by : Chris Frew

Johnathan Cohen., Founder, and Chief Executive Officer, 20/20 GeneSystems Inc. joins Rich Bendis to discuss cancer diagnostics, crowdfunding, and where his company is headed. Under Mr. Cohen’s leadership, 20/20 GeneSystems [….]